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Abstract 
Objective: We evaluated cardiometabolic burden in women planning assisted reproduction in order to 
identify subgroups at higher risk of pregnancy complications and cardiovascular disease. 
Materials and methods: In this cross-sectional study we investigated 60 infertile women with BMI≥25 
kg/m2 referred to the Center for Assisted Reproduction. All women underwent metabolic, anthropometric 
parameters and ultrasound evaluation of ectopic fat depots. 
Results: All women had waist ≥80 cm. We found that 93.3% of women had pathological subcutaneous, 
58.3% visceral and 80% para-perirenal fat; all women had fatty liver. Visceral fat and severity of 
steatosis were significantly related to the presence of metabolic syndrome (OR =5.7; p=0.03).  
A significant negative correlation between low HDL-c and para-perirenal fat (p<0.0001), a significant 
positive correlation with fasting plasma glucose and para-perirenal fat (p=0.001) were found. We 
observed a significant positive correlation between visceral fat and hs-CRP (p=0.002), HOMA-IR 
(p=0.04) and triglycerides (p=0.002), a significant negative correlation with HDL-c (p=0.05). 
Conclusion: This study by highlighting a clinically “dangerous liaison” between ectopic fat depots and 
metabolic/inflammatory markers, might permit to identify women with a worse metabolic phenotype and 
encourage lifestyle changes for improving their general and reproductive health together. 
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1Introduction 
The historically lower risk of cardiovascular disease 
in young women in comparison to men has created a 
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gender bias; beyond estrogens’ protection, 
atherosclerotic cardiovascular (CV) disease is still the 
major cause of mortality in women. 
Therefore, atherosclerotic cardiovascular disease 
prevention remains undisputed and should be 
delivered to women by promoting healthier lifestyles 
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and by modifying traditional, as well as emerging CV 
risk factors, such as hormonal status and negative 
pregnancy outcomes. 
It is noteworthy that obesity is related to 
cardiometabolic disorders (1), as it represents a strong 
risk factor for heterogeneous conditions including 
insulin resistance, type 2 diabetes mellitus, metabolic 
syndrome (MetS), atherogenic dyslipidemia, 
hypertension and other cardiovascular diseases, as well 
as non-alcoholic fatty liver disease (NAFLD). 
Recent insights suggest that besides obesity, fat 
distribution might be a better predictor of 
cardiovascular disease than obesity itself (2). In 
particular, ectopic fat depots with predominantly 
systemic effects, such as visceral and liver fat (3), 
which are often associated with insulin resistance, 
with atherogenic lipid profile and adverse metabolic 
phenotypes, independently of total adiposity (4,5), 
may contribute to increasing cardiometabolic risk. 
Moreover, accumulation of adipose tissue in ectopic 
sites such as para-perirenal and renal sinus fats, by 
inducing local effects, is possibly related to 
cardiovascular disease.  
Obesity has become a worldwide epidemic, and 
apart from cardiovascular diseases, it negatively affects 
reproductive potential.  Women with obesity are likely 
to have ovulatory dysfunction due to dysregulation of 
the hypothalamic-pituitary-ovarian axis (6), menstrual 
irregularities, infertility, and once pregnant, a wide 
range of obstetric and post-partum complications (7).  
In the real world, increasing age of women in 
getting pregnant, physiological lowering in ovarian 
function, often associated with comorbidities, could 
explain the higher percentage of women undergoing 
assisted reproduction. Data from clinical studies 
demonstrated that women with overweight/obesity 
are less likely to achieve a clinical pregnancy after 
assisted reproduction compared to normal weight 
women (8). Moreover, women with 
overweight/obesity are prone to have lower clinical 
pregnancy rates, lower live birth rates and potential 
increased cardiovascular risk assisted reproduction-
related, as compared with women of normal BMI (9). 
Recently, data from a study performed on women 
underwent ART provided evidence that weight gain 
is negatively associated with ART success, and in 
particular on probability of live birth following ART; 
this observation may support the benefits of 
preventing weight gain in female fertility (10). 
Actually, this topic remains the object of debate.  
Preventive medicine and adequate treatments for 
preconception cardiovascular risk factors might 
contribute to control the added risk carried by 
assisted reproduction, while strategies and 
interventions aimed to change modifiable 
cardiovascular risk factors might improve pregnancy 
outcome and lifetime health.   
The aim of the present study was to evaluate 
cardiometabolic burden in a model of women 
planning assisted reproduction, by investigating 
ectopic fat depots and their relationship with 
cardiometabolic risk factors, in order to identify 
subgroups of women at higher risk of pregnancy 
complications and cardiovascular disease. 
Materials and methods 
In this monocentric cross-sectional study, we 
investigated Caucasian infertile women with BMI 
≥25 kg/m2 planning assisted reproduction, at the 
Assisted Reproductive Technology Center, Division 
of Obstetrics and Gynecology, University Hospital, 
Careggi, Florence, Italy from February 2018 to 
November 2019. 
The entire study population comprised 60 women 
with overweight/obesity, who were referred to the 
Internal Medicine Clinic at the Assisted Reproduction 
Center, in order to be framed for their cardiovascular 
risk profile and to better define preconceptional 
behaviors before Assisted Reproduction.  
Information concerning cardiometabolic 
parameters derived from clinical reports and 
cardiovascular risk factors were investigated during 
the clinical evaluation. 
According to the World Health Organization criteria, 
overweight was defined as BMI values ≥25 Kg/m2, first 
grade obesity as BMI values ≥ 30 Kg/m2 and <30 
Kg/m2, and second grade obesity as BMI ≥35 Kg/m2.  
All anthropometric parameters were also 
measured; waist circumference was measured 
midway between the inferior margin of the lowest rib 
and the iliac crest in the horizontal plane at the end of 
normal expiration; hip circumference was measured 
at the widest point over the buttocks. A value ≥80 cm 
was considered a marker of increased cardiovascular 
risk according to Alberti et al. (11); WHR was 
obtained by dividing the waist circumference by hip 
circumference, and a value >0.80 was considered a 
marker of increased cardiovascular risk. 
Dyslipidemia was defined according to ESC 
guidelines (12). MetS was defined according to the 
2005 International Diabetes Federation criteria (11). 
Ultrasound evaluation (US) of intra-abdominal 
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(visceral) (VAT), subcutaneous (SAT), liver and 
para-perirenal fat were obtained. US-determined 
subcutaneous fat was defined as the distance between 
the skin and external face of linea alba, and visceral 
fat was defined as the distance between the internal 
face of linea alba and the anterior wall of the aorta. 
With the patient in the supine position, the probe was 
kept perpendicular to the skin 5 cm above the 
umbilical scar. Then longitudinal scanning was 
performed, and the probe was slowly moved laterally 
until the optimal position was found, at which the 
surface of the kidney was almost parallel to the skin. 
The thickness of fat (consisting of para- and perirenal 
fat) was measured from the inner side of the 
abdominal musculature to the surface of the kidney 
and designated ultrasound measure (UM) 
sonographic evaluation of visceral fat by measuring 
para- and perirenal fat. The average of the UM values 
on both sides was defined as the para- and perirenal 
ultrasound fat thickness (PUFT) (13). 
The pressure exerted on the probe was as minimal 
as possible so that the fat layers were not compressed. 
NAFLD was defined according to Fatty Liver 
Indicator (14). Sonographer was blinded to any other 
aspect of the study.  
Informed written consent for anonymous data 
analysis was obtained from all women. The 
investigation conforms to the principles outlined in 
the Declaration of Helsinki. The original study was 
approved by the Regional Ethical Committee  
(29 November 2016, CEAVC 10189, amendment  
16 May 2018, 2018-017 CINECA 10189). 
Statistical analysis: Statistical analysis was 
performed by using the SPSS (Statistical Package for 
Social Sciences, Chicago, USA) software for 
Windows (Version 25.0).  Continuous variables were 
expressed as median, range; categorical variables 
were expressed as n, (%). Chi-square or Fisher’s 
exact test were used to test for proportions of the 
categorical variables, as appropriate. Correlation 
analysis was measured by using Spearman's rho test. 
The association between ectopic fat depots and MetS 
was assessed by using logistic regression analysis. 
The odds ratio (OR) with 95% confidence interval 
(CI) was determined. A p-value <0.05 was considered 
to indicate statistical significance. Sample size 
calculation indicated that at least 52 subjects were 
sufficient to detect, with a statistical power of 80% 
(β) and a significance value of 0.05 (α), absolute 
differences in the prevalence of MetS (15), according 
to the presence of the ectopic fat depots investigated. 
Receiver operating characteristic (ROC) curve 
was used to establish cut-off values for the diagnosis 
of visceral obesity based on waist circumference 
value (known to be more strongly associated with CT 
subcutaneous fat values) (16). 
ROC curve analysis identified the cut-offs of  
53 cm for US-determined visceral fat (specificity of 
72.2%, sensitivity of 98.2%); for subcutaneous fat  
20 cm (specificity 77.8%, sensitivity 84.2%); for 
Para-Perirenal Ultrasound Fat Thickness 20 cm 
(specificity 94.4%, sensitivity 73.7%). 
Results 
Demographical and clinical characteristics of the 
study population are reported in Table 1. The median 
age of our study population was 41 (24-49 yrs).  The 
evaluation of traditional CV risk factors evidenced 
that 28 out of 60 women (46.7%) were overweight, 
and 32 (53.3%) were obese; as concern 
anthropometric parameters, all women had waist 
circumference ≥80 cm (100%); a high prevalence of 
dyslipidemia (76.7%), and smoking habit (15.6%), as 
well as impaired fasting glucose (20%), and 
hypertension (10%) were found. About 27% of 
women planning assisted reproduction had MetS, 
according to the IDF definition (11).  
 
Table 1: Demographic and clinical characteristics of 
infertile women planning Assisted Reproduction 
Variables Infertile women 
(n=60) 
Age, yrsa 41 (24-49) 
BMI 25-29.99 Kg/m2 28 (46.7) 
BMI 30-34.99 Kg/m2 24 (40) 
BMI 35-39.99 Kg/m2 8 (13.3) 
WAIST circumference ≥ 80 cm 60 (100) 
WHR > 0.8 48 (80) 
Smoking habit (current), n (%) 10 (15.6) 
Sedentary behaviour, n (%) 48 (80) 
Dyslipidemia, n (%) 46 (76.7) 
Hypertension, n (%) 6 (10) 
Impaired fasting glucose, n (%) 12 (20) 
Metabolic syndrome, n (%) 16 (26.7) 
Family history of CV disease, n (%)  22 (36.7) 
Migraine with aura, n (%) 6 (10) 
POI, n (%) 2 (3.3) 
PCOS, n (%) 10 (16.7) 
History of negative pregnancy 
outcomes, n (%) 
22 (36.7) 
Anti-hypertensive treatment, n (%) 6 (10) 
aValues are reported as median (range). WHR (Waist to Hip Ratio); POI 
(Premature Ovary Insufficiency); PCOS (Polycystic Ovary Syndrome); 
CV (cardiovascular).  
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As concerning traditional CV risk factors, 
evaluated according to overweight and obesity, we 
observed a higher, but not statistically significant 
prevalence of impaired fasting glucose in women 
with obesity than in women with overweight  
(25% vs. 14.3%), whereas no difference in the 
prevalence of both dyslipidemia and MetS was 
observed between women with overweight and 
women with obesity (75% vs. 78.1%; 28.6% vs. 25%, 
respectively). Hypertension was observed only in the 
group with obesity (18.8%). Values of waist 
circumference ≥80 cm, measure of visceral adiposity, 
were present in all women investigated, whereas 
WHR value >0.80 was present in 80% of infertile 
women; a significantly higher percentage of WHR 
value >0.80 was observed in women with obesity 
(93.8%), than that found in women with overweight 
(64.3%) (p=0.008). Biohumoral parameters are 
reported in Table 2. We observed elevated median 
levels of hs-CRP, total cholesterol and lipoprotein (a). 
 
Table 2: Cardiometabolic parameters of infertile 
women planning Assisted Reproduction 
Variables Infertile women 
(n=60) 
Total Cholesterol (mg/dl) 203 (144-269) 
LDL-c (mg/dl) 130 (68-195) 
HDL-c (mg/dl) 53.5 (31-85) 
Triglycerides (mg/dl) 95 (68-306) 
Lipoprotein (a) (mg/L) 383 (20-1750) 
Fasting plasma glucose (mg/dl) 89 (70-119) 
HbA1c (mmol/mol) 34 (23-39) 
HOMA-IR 2.3 (0.7-9) 
hs-CRP mg/L 5.3 (0.1-14) 
AST IU/L 18 (8-45) 
ALT IU/L 19 (7-48) 
GGT IU/L 20 (12-33) 
Creatinine mg/dl 0.7 (0.5-0.9) 
Fibrinogen mg/dl 378 (238-597) 
aValues are reported as median (range).  
HOMA-IR (Homeostatic Model Assessment of Insulin Resistance);  
hs-CRP (high sensitive C Reactive Protein). 
 
Ectopic fat depots and cardiometabolic burden 
We investigated SAT, VAT, PUFT, and liver fat and 
we observed that 56 (93.3%) women had pathological 
SAT storage, 35 (58.3%) VAT, and 48 (80%) PUFT 
and all women (100%) had NAFLD, defined 
according to Fatty Liver Indicator. Forty-six (76.7%) 
women had moderate, and 14 (23.3%) severe NAFLD. 
The univariable analysis showed that VAT and 
severity of steatosis were statistically significantly 
related to the presence of MetS (OR = 6; IC 95%,  
1.41-25.38; p=0.02, respectively). At multivariable 
analysis, adjusted for age and traditional cardiovascular 
risk factors (family history of cardiovascular disease, 
smoking habit, dyslipidemia, BMI, hypertension), VAT 
and severity of steatosis remained significantly 
associated with MetS (OR = 5.7; IC 95%, 1.22-26.66; 
p=0.03). In Table 3 we reported the correlation between 
cardiometabolic parameters and ectopic fat depots; we 
observed a significant correlation between pathological 
VAT storage and hs-CRP, HOMA-IR and triglycerides 
(rho=0.45, p=0.002, rho=0.39, p=0.04; rho=0.43, 
p=0.002, respectively), and a significant negative 
correlation with HDL-c (rho= -0.28, p=0.05). Finally, 
we also found a significant negative correlation between 
low HDL-c values and PUFT (rho= -0.55, p<0.0001), 
and a significant positive correlation with fasting plasma 
glucose and both SAT and PUFT (rho=0.28, p0=0.05 
and rho=0.45, p=0.001, respectively). 
Discussion  
This study supports the concept that obesity, 
conventionally defined by BMI ≥30 kg/m2, seems to 
be not representative of the global cardiometabolic 
risk burden. Data from the literatures suggest that fat 
distribution might be a better predictor of 
cardiovascular disease than obesity itself (3,17); and 
the evaluation of amount and distribution of ectopic 
fat depots might help to clarify the heterogeneity of 
obesity phenotypes. 
To date, in response to weight gain, both women and 
men have increased fatty acid release into blood; in 
particular, in women, a high concentration of 
triglycerides correlates more strongly with cardiovascular 
risk, even if the reason remains unknown (18). 
 
Table 3: Correlation between cardiometabolic parameters and ectopic fat depots 
Variables HDL-c LDL-c Triglycerides hs-CRP HOMA-IR Fasting plasma glucose 
VAT Rho -0.28 
p=0.05 
- Rho 0.43 
p=0.002 
Rho 0.45 
p=0.01 
Rho 0.39 
p=0.04 
- 
SAT - Rho 0.26 
p=0.08 
- - - Rho 0.28 
p=0.05 
PUFT Rho -0.55 
p <0.0001 
- - - - Rho 0.45 
p=0.001 
VAT (visceral adipose tissue); SAT (subcutaneous adipose tissue); PUFT (para-perirenal ultrasound fat thickness); hs-CRP 
(high sensitive C Reactive Protein); HOMA-IR (Homeostatic Model Assessment of Insulin Resistance). 
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In our study, we observed a strong association 
between VAT, liver fat and the presence of MetS. 
This suggests that the severity of steatosis and 
visceral fat were more closely linked to the MetS 
components, in comparison to other ectopic fat 
depots, providing an opportunity to identify a 
subgroup of women with a higher future risk of 
vascular disease.  
We also found a significant correlation between 
visceral adipose tissue and both increased 
triglycerides concentrations and HOMA-IR, as well 
as a decreased HDL-c. There are substantial 
experimental evidence that both higher levels of 
triglycerides and lower levels of HDL-c can be a 
consequence of insulin-resistance. Really, some 
mechanisms involving the activity of triglyceride 
lipases, have been proposed to account for this 
reduction in HDL-c as a consequence of insulin-
resistance (19). 
Metabolic syndrome, of which abdominal obesity 
is the main distinguishing feature, represents a 
constellation of metabolic abnormalities known as 
risk factors for cardiovascular disease. In order to 
explain the existing relationship between VAT and 
cardiometabolic risk, several mechanisms concerning 
lipolytic activity increased delivery of free fatty acids 
to the liver and consequently insulin-resistance, have 
been hypothesized. Furthermore, the liver, 
particularly susceptible to ectopic lipid accumulation, 
causally contribute to atherogenic dyslipidemia (high 
plasma triglyceride and reduced HDL-c) (20). 
Clinical data evidenced that visceral fat depot, by 
producing atherosclerotic cytokines, leads to low-
grade systemic inflammation (1). Our findings 
demonstrated a significant correlation between VAT 
and hs-CRP, a predictor of cardiovascular risk (21) 
produced by the liver upon stimulation by 
inflammatory cytokines; hs-CRP is a downstream 
marker of the IL-1b–IL-6 pathway and its 
measurement may increase overall cardiovascular 
risk assessment. This datum is at variance with a 
recent study (22), which suggested that visceral body 
fat and subclinical atherosclerosis were not mediated 
by inflammation as measured by hs-CRP. This 
conflicting result might be related to the clinical 
characteristic of our study population, which 
comprised younger women without history of 
diabetes and cardiovascular disease, and in the 
absence of lipid-lowering or antithrombotic therapy, 
known to their pleiotropic effects. 
At the best of our knowledge, no studies 
investigating PUFT in women with overweight/ 
obesity planning Assisted Reproduction are available. 
Our findings provided evidence of a significant 
correlation between para- perirenal fat and both lower 
HDL-C and increased fasting plasma glucose, 
parameters defining metabolic syndrome. These data 
are in keeping with those from Manno et al. (23), 
even if our population comprised only women, 
younger, and in preconception period. 
PUFT represents an atypical visceral fat, possibly 
involved in regulating cardiovascular risk through 
mechanisms including neural, humoral and kidney-
mediated regulation; noteworthy, PUFT is highly 
active in adipokines synthesis and abnormally 
involved in worsening glucose homeostasis (24).  
A limitation of the study might be the lack of 
ultrasounds evaluation in normal weight women. This 
imaging method not represents routinely screening 
test in our clinical assisted reproduction setting, but is 
addressed only to women at higher risk for 
cardiovascular disease. 
It is noteworthy that the distribution and 
contribution of metabolic syndrome components in 
defining cardiometabolic risk is specific to each 
population and that the relationship between lipid 
profiles and body fat distribution may vary by 
race/ethnicity in reproductive-age women. In our 
study all participants were Caucasians, and thus 
findings may not be generalizable to other racial and 
ethnic groups.  
To date, there are direct implications of obesity on 
maternal health as well as obstetric and perinatal 
outcomes, in particular, in women undergoing 
assisted reproduction (25). Moreover, there is 
developing research indicating that in utero 
environmental factors during specific developmental 
periods (preconception, conception, and gestation), 
influence chronic disease susceptibility later in life 
(26). 
Obesity is a reversible disorder, and strategies 
aimed to control this cardiovascular risk factor, might 
translate a “dysmetabolic” into a “healthy” vascular 
phenotype. The ideal timing for this virtuous 
transition is preconceptional period, as preconception 
care offers an opportunity for non-communicable 
disease prevention and health promotion among 
metabolically unhealthy women planning pregnancy 
after assisted reproduction, thus possibly improving 
their lifetime health. 
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Conclusion 
This study performed in women with overweight 
and women with obesity planning assisted 
reproduction, might permit to identify, through 
ultrasounds evaluation of ectopic fat depots, women 
with a worse metabolic phenotype. Our study 
allowed us to assess a better clinical risk 
stratification, and to encourage lifestyle changes for 
improving their general health and reproductive 
health together. Our findings highlight a clinically 
“dangerous liaison” between ectopic fat depots, such 
as VAT and PUFT, and metabolic and inflammatory 
markers, possibly contributing to improving our 
knowledge concerning the cross-talking between 
ectopic fat depots, cellular pathways and 
cardiovascular health in women planning assisted 
reproduction. Due to the small number of women 
investigated, this study must be considered as a 
“pilot study”, and further studies are required in 
order to reinforce the relevance of our findings. 
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